Company Analysis

Pacira BioSciences, Inc. (PCRX)

Nasdaq: PCRX · Pharmaceutical Preparations · Brisbane, CA · filing with the SEC since 2007
Grade6.3
◀ Past 8.0● Present 6.1▶ Future 4.9

Who runs Pacira BioSciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Lee Frank D.
Chief Executive Officer. First filing Jan 2024, latest Feb 13, 2026, 1 filing in all.
Officers reporting now
6
of 16 people with a filing in the last fifteen months
Directors reporting now
10
37 people on the record since 2011
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Cross ShawnChief Financial OfficerOct 2024Nov 3, 20267 · $1.5M
Riker Lauren BullaroSenior Vice President, FinanceMar 2012Oct 9, 20264 · $500,000
Slonin JonathanChief Medical OfficerJul 2021Aug 18, 20263 · $200,000
Williams Kristen MarieChief Administrative OfficerOct 2014Jun 5, 20262 · $500,000
Lee Frank D.Chief Executive OfficerJan 2024Feb 13, 2026none
Teehan BrendanChief Commercial OfficerJan 2025Feb 13, 2026none
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bigal MarcelodirectorOct 2023Jun 12, 2026none
Brege LauradirectorJun 2011Jun 12, 2026none
Christie ChristopherdirectorSep 2019Jun 12, 2026none
Froimson MarkdirectorJun 2017Jun 12, 20261 · $0.00
Hirawat SamitdirectorJan 2026Jun 12, 2026none
Wiggans Thomas GdirectorJun 2026Jun 12, 2026none
Yang Michael J.directorOct 2023Jun 12, 2026none
Young AlethiadirectorOct 2023Jun 12, 2026none
Kronenfeld Mark A.directorJun 2013Mar 19, 2026none
Ceesay AbrahamdirectorOct 2023Sep 8, 2025none
Earlier names on the record21, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PCRX · research, not advice